IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic

First Page		Document Content
Date: 2015-11-10 06:17:54 Medicine Anatomy Blood Coagulation system Acquired hemolytic anemia Blood disorders Rare diseases Hemolytic-uremic syndrome Nephrology Thrombotic thrombocytopenic purpura Thrombotic microangiopathy Von Willebrand factor		IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic Add to Reading List Source URL: www.sanquin.nl Download Document from Source Website File Size: 23,51 KB Share Document on Facebook

	What is MDS? (MDS Foundation, 2011) • MDS is a group of bone marrow disorders. The bone marrow is the factory for the production of blood cells including red blood cells, white blood cells, and platelets. In MDS, the DocID: 1vge2 - View Document
	2018 Sponsor Opportunities About the CCC The Children’s Cancer Center (CCC) is a nonprofit organization dedicated to serving children who have cancer or chronic blood disorders and DocID: 1uGKK - View Document
	Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial Gotsopoulos H, Kelly JJ, Cistulli PA. SleepAug 1;27(5):Department of Respiratory & Sleep Medicine, S DocID: 1r0Mv - View Document
	IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic DocID: 1pS8s - View Document
	Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris DocID: 1pPKn - View Document